Scarica l'app Stockscreener
22.75
1.09%
-0.25
Dopo l'orario di chiusura:
22.75
Precedente Chiudi:
$23.00
Aprire:
$22.59
Volume 24 ore:
6,768
Relative Volume:
3.55
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.09%
1M Prestazione:
+2.25%
6M Prestazione:
+10.71%
1 anno Prestazione:
+22.97%
Intervallo 1D:
$21.51
$22.75
Intervallo di 1 settimana:
$21.51
$23.50
Portata 52W:
$17.15
$25.00
Lifemd Inc Stock (LFMDP) Company Profile
Nome
Lifemd Inc
Settore
Industria
Telefono
866 351 5907
Indirizzo
236 Fifth Avenue, Suite 400, New York
Confronta LFMDP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| LFMDP | 22.75 | 0 | 0 | 0 | 0 | 0.00 |
| WBA | 8.66 | 7.48B | 147.66B | -8.64B | -363.00M | -3.57 |
| HITI | 2.57 | 208.95M | 376.07M | -22.41M | 18.73M | -0.7065 |
| PETS | 4.47 | 94.95M | 270.52M | -6.08M | 17.42M | -0.1609 |
| SCNX | 8.36 | 67.16M | 0 | 0 | 0 | 0.00 |
| CJJD | 2.01 | 14.37M | 148.81M | -21.14M | 0 | -0.9969 |
Lifemd Inc Borsa (LFMDP) Ultime notizie
Los Angeles Capital Management LLC Acquires 108,822 Shares of LifeMD, Inc. (NASDAQ:LFMD) - MarketBeat
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMDP Stock News - StockTitan
LifeMD to Participate in Three Investor Conferences During November - The Manila Times
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMD Stock News - StockTitan
LifeMD Inc (NASDAQ: LFMD) Could Pass $12 In One Year Stock Forecast - Stocks Register
HC Wainwright Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Call Transcript - Insider Monkey
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story - Simply Wall St
LifeMD Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
(LFMD) Technical Pivots with Risk Controls - Stock Traders Daily
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Teleh - GuruFocus.com
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD, Inc. (LFMD) Reports Q3 Loss, Lags Revenue Estimates - MSN
LifeMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
LifeMD Reports Third Quarter 2024 Results - The Manila Times
LifeMD earnings beat by $0.21, revenue fell short of estimates - Investing.com UK
Institutions profited after LifeMD, Inc.'s (NASDAQ:LFMD) market cap rose US$39m last week but individual investors profited the most - Simply Wall St
Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result - GuruFocus.com
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency - The Manila Times
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.00 - Defense World
Medifast Announces Third Quarter 2024 Financial Results - StockTitan
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by Brokerages - MarketBeat
LifeMD announces board member resignation By Investing.com - Investing.com Australia
LifeMD announces board member resignation - Investing.com India
LifeMD stock touches 52-week low at $4.03 amid market challenges - Investing.com Canada
LifeMD (LFMD) Set to Announce Earnings on Thursday - MarketBeat
LifeMD Shares Decline Even After the Launch of Testosterone Therapy - MSN
LifeMD® To Report Third Quarter 2024 Financial Results On November 7 - Barchart
LifeMD launches TestoRx, direct to consumer testosterone replacement therapy - Yahoo Finance
LifeMD® to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering - Yahoo Finance
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Trading Day Review: LifeMD Inc (LFMD) Gains Momentum, Closing at 4.64 - The Dwinnex
LifeMD shares hold as BTIG maintains $12 target By Investing.com - Investing.com Australia
LifeMD shares hold as BTIG maintains $12 target - Investing.com
Is it possible to buy LifeMD Inc(LFMD) shares at a good price now? - US Post News
LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions - Yahoo Finance
LifeMD Inc [LFMD] stock for 14,790 USD was bought by Galluppi Stefan - Knox Daily
LifeMD Inc (LFMD) Stock: A Year of Declines and Increases - The InvestChronicle
Financial Health Check: Examining LifeMD Inc (LFMD)’s Key Ratios - The Dwinnex
LifeMD shares maintain Buy rating from B.Riley amid market demand By Investing.com - Investing.com South Africa
LifeMD Inc (LFMD) Q2 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD shares maintain Buy rating from B.Riley amid market demand - Investing.com
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) PT at $12.00 - MarketBeat
LifeMD Inc (LFMD)’s results reveal risk - US Post News
Trend Tracker for (LFMDP) - Stock Traders Daily
LifeMD stock well-positioned as branded prescriptions gain traction – BTIG By Investing.com - Investing.com Canada
LifeMD Inc [LFMD] stock for 14,790 USD was acquired by Galluppi Stefan - Knox Daily
Lifemd Inc Azioni (LFMDP) Dati Finanziari
Non sono disponibili dati finanziari per Lifemd Inc (LFMDP). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
4.50%
Capitalizzazione:
|
Volume (24 ore):